diff --git a/pages/STOP2030___Viaje a Ghana 2023.md b/pages/STOP2030___Viaje a Ghana 2023.md
index 1c417193..0c705e4b 100644
--- a/pages/STOP2030___Viaje a Ghana 2023.md	
+++ b/pages/STOP2030___Viaje a Ghana 2023.md	
@@ -49,4 +49,8 @@ date:: [[2023/12]]
 			- Full draft protocol Q1 2024 (after formative research)
 		- 3 dose regimen
 			- Continue to include – potential to inform future MDA design and improved effectiveness/cost effectiveness of MDAs, improved clinical management
-			- Alejandro to share potential protocol/design for salivary testing of [[Albendazol]] (e.g. 48 hours after dose 3) to complement
\ No newline at end of file
+			- Alejandro to share potential protocol/design for salivary testing of [[Albendazol]] (e.g. 48 hours after dose 3) to complement reported coverage data.
+		- Economics – Contributes also to WP3 (KEMRI)
+			- GHS RDD to consider options for inclusion of key costing data points
+				- Discuss with GHS economist
+				- Discuss with KEMRI (e.)
\ No newline at end of file